Many moons ago I was Head of Finance at Celltech, the biotechnology company. Some R&D costs were project or department-specific, but others were allocated by the number of people in each section.
Then the first manufacturing process started. Initially the same cost basis was used, but this began to produce bizarre decisions, such as [...read more...]